88R9542 TBO-D
 
  By: Lalani H.R. No. 77
 
 
 
R E S O L U T I O N
         WHEREAS, Hypertrophic Cardiomyopathy Awareness Day is taking
  place on February 22, 2023, and this occasion provides a fitting
  opportunity to promote better understanding of this health issue;
  and
         WHEREAS, Hypertrophic cardiomyopathy (HCM) is a chronic
  cardiovascular disease that involves thickening of the heart muscle
  and can potentially lead to debilitating symptoms and serious
  complications, including heart failure, atrial fibrillation,
  stroke, and in rare cases, sudden cardiac death; and
         WHEREAS, HCM is the most common inheritable heart disease; it
  can affect anyone, regardless of age, gender, or ethnicity, and it
  has a reported prevalence ranging from 1 in 200 individuals to 1 in
  500 individuals in the general population; an estimated 58,722 to
  146,804 people in Texas have HCM, although approximately 85 percent
  of them remain undiagnosed; and
         WHEREAS, HCM shares symptoms with other common
  cardiovascular and pulmonary diseases, such as shortness of breath,
  chest pain, fatigue, palpitations, and fainting, and those
  similarities make it difficult to accurately diagnose HCM; in
  addition, the all-cause mortality risk is three to four times
  higher in patients with HCM than that of the general population; in
  order to receive a diagnosis, patients should know their medical
  history and stay informed about the signs and symptoms of HCM; and
         WHEREAS, Health care providers must conduct thorough
  screenings with cardiac health questions to help identify a risk of
  both genetic and congenital cardiac disorders; they may also
  conduct several tests, including an echocardiogram, a cardiac MRI,
  or genetic testing to confirm a family history of HCM, and they must
  examine the heart to diagnose HCM; and
         WHEREAS, Following a diagnosis of HCM, it is important for
  patients to work with their health care providers to learn more
  about the disease and different management options, such as
  prescription medicines and surgical treatments; and
         WHEREAS, Hypertrophic cardiomyopathy is a serious and
  life-threatening disease, and the observance of Hypertrophic
  Cardiomyopathy Awareness Day unites people around the world in
  their commitment to improving the quality of life for patients;
  now, therefore, be it
         RESOLVED, That the House of Representatives of the 88th Texas
  Legislature hereby recognize February 22, 2023, as Hypertrophic
  Cardiomyopathy Awareness Day and urge all Texans to learn more
  about the disease; and, be it further
         RESOLVED, That an official copy of this resolution be
  prepared for the Hypertrophic Cardiomyopathy Association as an
  expression of high regard by the Texas House of Representatives.